Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis.

Q4 Medicine

Journal of Tehran University Heart Center Pub Date : 2023-04-01 DOI:10.18502/jthc.v18i2.13316

Mohammad Reza Beyranvand, Hootan Manhoobi, Saeid Shahraz, Ali-Asghar Kolahi

{"title":"Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis.","authors":"Mohammad Reza Beyranvand, Hootan Manhoobi, Saeid Shahraz, Ali-Asghar Kolahi","doi":"10.18502/jthc.v18i2.13316","DOIUrl":null,"url":null,"abstract":"Background: Cardiovascular diseases, specifically acute myocardial infarction (AMI), are the leading cause of death worldwide. In this review, we explain the characteristics of AMI in Iran.Methods: We searched PubMed, Google, and Google Scholar for articles containing myocardial infarction, STEMI, and MI+ Iran in English and Persian words.Results: The age-standardized incidence rate of MI was 73.3 per 100 000. The mean±SD age of patients was 61.20±13.40 years. In-hospital mortality of patients with AMI in the IMIR was 12.1%. Concerning AMI complications reported in the IMIR, 5.8% of patients experienced ventricular tachycardia, and 2.5% experienced ventricular fibrillation. The 1-year mortality rate in the IPACE2 study was 4.3%.Conclusion: Only a few national studies are available in Iran regarding patients with AMI. A federal surveillance program continuously monitoring and tracking coronary events is essential to improve the general population's health.","PeriodicalId":39149,"journal":{"name":"Journal of Tehran University Heart Center","volume":"18 2","pages":"82-86"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/d6/JTHC-18-82.PMC10459342.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Tehran University Heart Center","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/jthc.v18i2.13316","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Cardiovascular diseases, specifically acute myocardial infarction (AMI), are the leading cause of death worldwide. In this review, we explain the characteristics of AMI in Iran.

Methods: We searched PubMed, Google, and Google Scholar for articles containing myocardial infarction, STEMI, and MI⁺ Iran in English and Persian words.

Results: The age-standardized incidence rate of MI was 73.3 per 100 000. The mean±SD age of patients was 61.20±13.40 years. In-hospital mortality of patients with AMI in the IMIR was 12.1%. Concerning AMI complications reported in the IMIR, 5.8% of patients experienced ventricular tachycardia, and 2.5% experienced ventricular fibrillation. The 1-year mortality rate in the IPACE2 study was 4.3%.

Conclusion: Only a few national studies are available in Iran regarding patients with AMI. A federal surveillance program continuously monitoring and tracking coronary events is essential to improve the general population's health.

Abstract Image

查看原文本刊更多论文

伊朗心肌梗死:流行病学、管理和预后。

背景:心血管疾病，特别是急性心肌梗死(AMI)，是世界范围内死亡的主要原因。在这篇综述中，我们解释AMI在伊朗的特点。方法:我们用英文和波斯语检索PubMed、Google和Google Scholar中包含心肌梗死、STEMI和MI+ Iran的文章。结果:心肌梗死年龄标准化发病率为73.3 / 10万。患者平均±SD年龄为61.20±13.40岁。AMI患者在IMIR中的住院死亡率为12.1%。关于IMIR报告的AMI并发症，5.8%的患者出现室性心动过速，2.5%的患者出现心室颤动。IPACE2研究的1年死亡率为4.3%。结论:在伊朗只有少数关于AMI患者的全国性研究。一项持续监测和跟踪冠状动脉事件的联邦监测计划对于改善一般人群的健康至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Tehran University Heart Center Medicine-Cardiology and Cardiovascular Medicine

CiteScore

0.90

自引率

0.00%

发文量

审稿时长

12 weeks